Orphazyme Statistics
Orphazyme (1TB0) Stock Statistics & Valuation Metrics
Total Valuation
Orphazyme has a market cap or net worth of EUR 4.23M. The enterprise value is EUR 26.44T.
- Market Cap
- EUR 4.23M
- Enterprise Value
- EUR 26.44T
Share Statistics
Orphazyme has 54,112 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 54,112
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Orphazyme’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -57.94M
- Employee Count
- 1
- Asset Turnover
- ―
- Inventory Turnover
- ―
Valuation Ratios
The current PE Ratio of Orphazyme is 18.12. Orphazyme’s PEG ratio is 0.03.
- PE Ratio
- 18.12
- PS Ratio
- 59.14
- PB Ratio
- 1.26
- Price to FCF
- 20.98
- Price to Operating Cash Flow
- 21.16
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, Orphazyme had revenue of ― and earned -57.94M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- ―
- Operating Income
- -63.52M
- Pretax Income
- ―
- Net Income
- -57.94M
- EBITDA
- -62.66M
- Earnings Per Share (EPS)
- ―
Cash Flow
- Operating Cash Flow
- 1.15M
- Free Cash Flow
- 1.15M
- Free Cash Flow per Share
- 27.64
Dividends & Yields
Orphazyme pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.94%
- Earnings Yield
- 5.72%
Stock Price Statistics
- Beta
- -0.29
- 52-Week Price Change
- -31.00%
- 50-Day Moving Average
- 84.51
- 200-Day Moving Average
- 81.03
- Relative Strength Index (RSI)
- 45.86
- Average Volume (3m)
- 8
Important Dates
Orphazyme upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Sep 02, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Enterprise Valuation
Orphazyme EV to EBITDA ratio is -12.10, with an EV/FCF ratio of 20.20.
- EV to Sales
- 56.95
- EV to EBITDA
- -12.10
- EV to Free Cash Flow
- 20.20
- EV to Operating Cash Flow
- 20.20
Balance Sheet
Orphazyme has ― in cash and marketable securities with EUR 9.54M in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- EUR 9.54M
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Margins
Gross margin is 100.00%, with operating margin of -470.66%, and net profit margin of 329.34%.
- Gross Margin
- 100.00%
- Operating Margin
- -470.66%
- Pretax Margin
- 329.34%
- Net Profit Margin
- 329.34%
- EBITDA Margin
- -470.66%
- EBIT Margin
- -470.66%
